A trial of directed therapy in younger patients with acute myeloid leukaemia: MRC AML 15
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
2003 Results article in http://www.ncbi.nlm.nih.gov/pubmed/12933575 results of a feasibility study 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/19965647 results 2010 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/20385793 pooled analysis of prognostic significance of rare recurring chromosomal abnormalities 2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22875911 results 2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23439754 results 2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/23940227 results 2014 Results article in http://www.ncbi.nlm.nih.gov/pubmed/24855211 results 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29025912 results (added 25/07/2019)
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Any form of de novo or secondary AML
- •2. Suitable for intensive chemotherapy
- •3. Under 60 years
- •4. Written consent
排除标准
- •1. Previous chemotherapy for AML
- •2. Blast transferration of CML
- •3. Pregnant or lactating
- •4. Abnormal liver function tests for Mylotarg randomisations
